Breaking News, Financial News

Financial Report: GlaxoSmithKline 4Q

Pharmaceutical sales in the quarter were $9.3 billion (-9%) and $37.7 billion for the year (-2%). Advair sales were $2.8 billion in the quarter (+47%) and $10.8 billion for the year (+54%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GlaxoSmithKline 4Q 4Q Revenues: $11.0 billion (-9%) 4Q Earnings: $1.5 billion (-32%) FY Revenues: $45.1 billion (-1%) FY Earnings: $8.7 billion (-18%) Comments: Pharmaceutical sales in the quarter were $9.3 billion (-9%) and $37.7 billion for the year (-2%). Advair sales were $2.8 billion in the quarter (+47%) and $10.8 billion for the year (+54%). Flovent sales were $337 million in the quarter (-5%) and flat at $1.3 billion for the year. Paxil sales were $249 million in the quart...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters